Abstract Details

Title Myelin water imaging provides evidence of long-term remyelination and neuroprotection in Alemtuzumab treated multiple sclerosis patients

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 335

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Irene Vavasour, PhD (University of British Columbia) PRESENTER	Dr. Vavasour has nothing to disclose.
Cornelia Laule, PhD (University of British Columbia)	The institution of Dr. Laule has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Laule has received research support from Natural Sciences and Engineering Research Council of Canada (NSERC). The institution of Dr. Laule has received research support from International Collaboration on Repair Discoveries (ICORD).
	No disclosure on file
Roger Tam, PhD (University of British Columbia, MS/MRI Research Group)	The institution of Dr. Tam has received research support from Natural Sciences and Engineering Research Council. The institution of Dr. Tam has received research support from Praxis Spinal Cord Institute.
David K. Li, MD (University of British Columbia)	Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers.
	No disclosure on file
Anthony Traboulsee, MD (University of British Columbia)	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme.